Kiniksa Pharmaceuticals, Ltd. (KNSA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 50.2M | 53.89M | 33.68M | 28.09M | 22.32M | 18.77M | -2.24M | 5.17M | 3.99M | 4.33M | 16.99M | -3.74M |
| Operating CF Margin % | 23.43% | 26.66% | 18.62% | 17.91% | 16.2% | 15.32% | -1.99% | 4.76% | 4.99% | 5.19% | 25.33% | -5.24% |
| Operating CF Growth % | 124.87% | 187.13% | 1606.13% | 443.54% | 459.92% | 333.99% | -113.16% | 238.07% | 193.44% | 137.36% | -72.63% | 52.16% |
| Net Income | 22.59M | -88M | 18.43M | 17.83M | 8.54M | -8.89M | -12.69M | -3.91M | -17.7M | 25.24M | -13.86M | 14.97M |
| Depreciation & Amortization | 1.77M | 339K | 384K | 358K | 345K | 400K | 399K | 430K | 466K | 236K | 603K | 602K |
| Stock-Based Compensation | 10.06M | 3.92M | 10.14M | 8.88M | 7.75M | 8.3M | 7.83M | 7.36M | 7.21M | 7.77M | 6.79M | 6.47M |
| Deferred Taxes | 4.52M | -1.73M | 4.23M | 2.64M | 2.99M | -3.16M | -3.64M | 10.57M | 4.37M | -25.71M | 10.29M | -19.44M |
| Other Non-Cash Items | 11.26M | 119.93M | 1.5M | 46K | 1.1M | 1.59M | 267K | 624K | 1.08M | 749K | 2.15M | -383K |
| Working Capital Changes | 0 | 19.43M | -1.02M | -1.67M | 1.6M | 20.54M | 5.6M | -9.91M | 8.58M | -3.96M | 11.01M | -5.96M |
| Change in Receivables | -7.63M | 36.15M | -19.83M | 8.15M | 1.66M | -16.84M | -4.44M | -4.46M | 5.27M | -18.23M | 21.61M | -17.23M |
| Change in Inventory | -18.25M | -13.5M | 6.79M | -26.11M | 4.29M | 2.32M | 6.18M | -7.58M | 3.84M | -5.54M | -1.63M | -533K |
| Change in Payables | 22.27M | -10.57M | -2.73M | 6.93M | 62K | -6.28M | 911K | 1.73M | -2.66M | 7.23M | 364K | -743K |
| Cash from Investing | -31.92M | -70.81M | -62.76M | -3.88M | -51.54M | 65.29M | -6.35M | -46.8M | 25.52M | -14.89M | -12.28M | 35.53M |
| Capital Expenditures | -161K | 658K | -671K | -165K | -99K | -193K | 0 | 0 | -84K | -56K | -16K | -34K |
| CapEx % of Revenue | 0.08% | 0.33% | 0.37% | 0.11% | 0.07% | 0.16% | - | - | 0.11% | 0.07% | 0.02% | 0.05% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | -25K | 0 | 0 | 14.84M | 12.26M | -35.57M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -226.64M | 0 | 0 | 0 | 0 | 25K | 25K | 0 | -14.84M | -12.26M | 35.57M |
| Cash from Financing | 6.07M | 7.66M | 11.9M | 10.7M | 2.77M | 2.14M | 6.69M | -178K | 3.61M | 695K | 552K | 158K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -918K | -4.35M | -2.05M | -412K | -578K | -2.71M | -1.31M | -381K | -262K | -1.1M | -419K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -918K | -4.35M | -2.05M | -412K | -578K | -2.71M | -1.31M | -381K | -262K | -1.1M | -419K |
| Other Financing | 6.07M | 8.58M | 16.25M | 12.74M | 3.18M | 2.72M | 9.4M | 1.14M | 3.99M | 957K | 1.66M | 577K |
| Net Change in Cash | 24.36M | -9.26M | -17.18M | 34.91M | -26.45M | 86.2M | -1.9M | -41.81M | 33.12M | -9.87M | 5.26M | 31.95M |
| Free Cash Flow | 50.04M | 53.26M | 33.01M | 27.93M | 22.23M | 18.58M | -2.24M | 5.17M | 3.9M | 4.27M | 16.97M | -3.78M |
| FCF Margin % | 23.35% | 26.35% | 18.25% | 17.81% | 16.13% | 15.16% | -1.99% | 4.76% | 4.89% | 5.12% | 25.31% | -5.28% |
| FCF Growth % | 125.14% | 186.7% | 1576.12% | 440.34% | 469.43% | 335.16% | -113.18% | 236.83% | 190.96% | 136.98% | -72.64% | 52.42% |
| FCF per Share | 0.61 | 0.67 | 0.42 | 0.36 | 0.29 | 0.26 | -0.03 | 0.07 | 0.06 | 0.06 | 0.24 | -0.05 |
| FCF Conversion (FCF/Net Income) | 2.22x | 3.80x | 1.83x | 1.58x | 2.61x | -2.11x | 0.18x | -1.32x | -0.23x | 0.17x | -1.23x | -0.25x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 1K | 3.01M | 1.26M | -769K | 1.51M | 0 | -1.31M | 201K | 3.52M |